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INTRODUCTION
Leber congenital amaurosis (LCA; MIM# 204000) is characterized by blindness or severe visual impairment at birth or within the first months of life. Infantile severe cone-rod-or cone dystrophy (CORD, COD) and retinitis pigmentosa (RP) may be clinically indistinguishable from LCA. About 30 LCA genes are known whose (mostly recessive) mutations lead to photoreceptor cell death and account for, depending on the population, at least 62% of cases . Many LCA genes encode proteins of the photoreceptor's connecting cilium, a structure that, together with the outer segment, corresponds to a highly specialized primary cilium [Wheway et al., 2013] . Several syndromic ciliopathies, including Joubert syndrome (JBTS; MIM# 213300), are allelic to LCA. JBTS is a rare, mostly autosomal recessive developmental disorder with a characteristic midbrain-hindbrain malformation ("molar tooth sign"), ataxia, psychomotor delay, oculomotor apraxia, and an altered respiratory pattern in the neonatal period. Several other organs apart from the brain may be affected: Most common are retinal degeneration either as LCA or RP; renal cysts, typically as nephronophthisis (NPHP); liver fibrosis; and skeletal involvement, e.g. polydactyly. All known JBTS genes play a role in the formation or function of primary cilia and/or associated structures like the basal body and the centrosomes [Romani et al., 2013] . Here, we report the identification of a mutation in POC1B (MIM# 614784) that encodes a core centriole component essential for basal body stability and ciliogenesis in a family with LCA, JBTS and atypical polycystic kidney disease (PKD). Our findings indicate a crucial role of POC1B for retinal function, supported by a recent independent study on a family with autosomal recessive non-syndromic CRD caused by the same POC1B mutation [Durlu et al., 2014] .
MATERIALS AND METHODS

Ethical approval
Blood samples for DNA extraction were obtained with written informed consent. All investigations were conducted according to the Declaration of Helsinki, and the study was approved by the institutional review board of the Ethics Committee of the University Hospital of Cologne.
Exclusion of mutations in known disease genes
NGS for a gene panel covering 21 JBTS genes, 76 genes associated with autosomal recessive and/or dominant RP, and 27 LCA genes, was carried out on an Illumina HiSeq1500 platform. Enrichment and filtering of data were carried out as described previously, and we applied quantitative readout of NGS reads . We thereby excluded large structural rearrangements such as exon deletions or duplications, with special attention to NPHP1 (homozygous deletion of NPHP1 is a common cause of JBTS with NPHP [Hildebrandt et al., 1997] ) and CEP290 (which is contained in one of the mapped candidate regions). PKHD1 was analyzed by direct sequencing of all coding exons.
Homozygosity mapping and whole-exome sequencing (WES)
Genome-wide linkage analysis was carried out with DNA from the index patient, his brother and his parents, using the Illumina HumanCoreExome-12v1-1 BeadChip (Illumina Inc., San Diego, CA) according to the manufacturer's protocol. Linkage analysis was performed assuming autosomal recessive inheritance, full penetrance, consanguinity and a disease gene frequency of 0.0001. Multipoint LOD scores were calculated using the program ALLEGRO [Gudbjartsson et al., 2000] . All data handling was done using the graphical user interface ALOHOMORA [Rüschendorf and Nürnberg, 2005] . WES and mapping of reads was carried out as previously described [Basmanav et al., 2014] . Filtering and variant prioritization was performed using the Cologne Center for Genomics' VARBANK database and analysis tool (https://varbank.ccg.uni-koeln.de). In particular, we filtered for high-quality (coverage >15-fold; phred-scaled quality >25), rare (MAF (minor allele frequency)≤0.001), homozygous variants (dbSNP build 135, the 1000 Genomes database build 20110521, and the public Exome Variant Server, NHLBI Exome Sequencing Project, Seattle, build ESP6500). To exclude pipeline-related artefacts (MAF≤0.01), we filtered against variants from in-house WES datasets from 511 epilepsy patients. Because our index patient comes from a consanguine background, we also filtered for variants contained in runs of homozygosity. Although compound heterozygous mutations are less likely to be the cause of disease in this family, we also filtered for genes carrying at least two rare variants in the index patient (Supp . Table S1 ).
Mutation analysis
Confirmation of the homozygous c.317G>C (p.Arg106Pro) mutation in POC1B and segregation analysis were carried out by Sanger sequencing. For mutation screening, we searched WES datasets from 19 unrelated JBTS patients without mutations in known disease genes for POC1B variants. In four JBTS patients with ocular-renal disease expression, we PCR-amplified the 12 protein-coding exons (GenBank accession number NM_172240.2), followed by Sanger sequencing. Primers and PCR conditions are available on request. The POC1B mutation described in this manuscript has been submitted to the Leiden Open Variation Database (LOVD v.3.0), http://www.lovd.nl/POC1B.
In silico assessment of the p.Arg106Pro mutation and the p.Arg106Gln polymorphism (rs76216585) Evolutionary conservation of the p.Arg106 residue was determined by alignment of the respective peptide stretches from seven species using ClustalW2 (https://www.ebi.ac.uk/ Tools/msa/clustalw2). The structure of POC1B was predicted using an algorithm we recently developed, the WD40 structure predictor, WDSP [Wang et al., 2013] . Modeling of POC1B structure was also carried out for a rare dbSNP-annotated variant that affects the same nucleotide position as c.317G>C (rs76216585; c.317G>A), which leads to a different missense variant, p.Arg106Gln.
Endogenous expression of mutant POC1B and immunofluorescence staining of POC1B in transfected HEK293T cells
Lymphoblastoid cell lines (LCL) from patient V:12 and his father were generated following standard protocols. POC1B expression was assessed in lysates from LCL, HepG2 cells, and POC1B-transfected HEK293T cells. Cells were harvested in Laemmli buffer, and protein from whole cell lysates was separated on 10% acrylamide gels in tris-glycine buffer (SDS-PAGE). Anti-POC1A/B [Hames et al., 2008] diluted 1:500 to probe membranes for 2 hrs, and HRP-conjugated anti-rabbit IgG secondary antibodies (Dako, Agilent Technologies, Santa Clara, CA), diluted 1:4,000, were used to analyse POC1 expression. The human hPOC1B-WT.eGFP plasmid was generated by PCR amplification and subcloning of hPOC1B with an EST-clone as template (BC026080; MRC geneservice, Cambridge, UK) into pEGFP-N1 (Clontech, Takara, Kyoto, Japan) as described before [Hames et al., 2008] . The mutation p.Arg106Pro was introduced using Quickchange mutagenesis according to standard protocols and confirmed by sequencing of the mutant plasmid, hPOC1B-R106P.eGFP. Cells from the human embryonic kidney cell line 293T (HEK 293T) were maintained in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10% FBS (fetal bovine serum), seeded onto coverslips and then transfected with the indicated plasmids using Lipofectamine2000 (Invitrogen, Life Technologies, Carlsbad, CA). 24 hours after transfection cells were rinsed with PBS several times and fixed with 4% PFA for 10 min. After blocking with 5% normal donkey serum and 0.1% Triton X-100 in dPBS, cells were sequentially stained with rabbit anti-pericentrin (pAB, Abcam (Cambridge, UK), ab4448; primary antibody) and Cy3-conjugated anti-rabbit-IgG (Jackson ImmunoResearch (West Grove, PA): secondary antibody). Coverslips were mounted with Prolong Gold (Invitrogen) and subjected to immunofluorescence microscopy. Pictures were taken with an Axiovert 200 microscope (objective: C-Apochromat 63×/1.22 W) equipped with an Axiocam MRm and the Apotome system (Carl Zeiss MicroImaging, Jena, Germany) using Axiovision 4.8 for acquisition and subsequent image processing (Carl Zeiss MicroImaging).
Determination of POC1B localization in the human retina
Eyes from a healthy human donor (#199-10; aged 56, dissection 29 hours post mortem) were obtained from the Department of Ophthalmology, Mainz, Germany, and guidelines to the declaration of Helsinki were followed. All animal experiments conform to the statement by the Association for Research in Vision and Ophthalmology (ARVO) as to care and use of animals in research. Adult C57BL/6J mice were maintained under a 12 hour light-dark cycle, with food and water ad libitum. After sacrifice eyeballs were dissected, cryofixed, sectioned, and immunolabeled as previously described [Overlack et al., 2011] . For indirect immunohistochemical experiments primary antibodies monoclonal antibodies to centrin-3 were used as a molecular marker for the ciliary apparatus of photoreceptors [Trojan et al., 2008] , and polyclonal antibodies to POC1B were purchased from Atlas (Stockholm, Sweden). Washed cryosections were incubated with antibodies conjugated to Alexa 488 or Alexa 568 (Invitrogen) in PBS with DAPI (Sigma-Aldrich, St. Louis, MO) to stain the DNA in nuclei and mounted in Mowiol 4.88 (Hoechst, Frankfurt, Germany) . Specimens were analyzed in a Leica LEITZ DM6000B deconvolution microscope (Leica, Wetzlar, Germany). Image contrast was adjusted with Adobe Photoshop CS using different tools including color correction.
Zebrafish experiments
All experiments were approved and performed in accordance with guidelines specified by the University of Oregon IACUC. Morpholino oligonucleotides (GeneTools (Philomath, OR), sequences published in [Pearson et al., 2009] ) were injected into one-cell stage embryos obtained from Oregon AB X TU mating crosses. Total RNA was extracted from pooled samples of five morpholino-injected or control embryos using the Qiagen RNeasy Kit. Reverse transcription reactions were performed using the SuperScript III Reverse Transcriptase kit (Invitrogen). Transcript variants were detected by PCR using cDNA from the reverse transcription and previously described primers [Pearson et al., 2009] . PCR fragments were sequenced (Genewiz, South Plainfield, NJ) and analyzed using Lasergene software. Cryosectioning and histology was performed as described [Phillips et al., 2013] with the following primary antibody dilutions: anti-acetylated tubulin (Santa Cruz Biotechnology, Santa Cruz, CA) 1:1000; Anti-active caspase 3 (BD Pharmingen, San Diego, CA) 1:500; Anti-actin (MAB1501, Sigma); Zpr-1 (Zebrafish International Resource Center, Eugene, OR): 1:500. Alexa-fluor 568 Goat anti-rabbit and 488 goat anti-mouse secondary antibodies (Life Technologies) were used at dilutions of 1:1000. Whole larvae images were obtained on a Leica dissecting microscope mounted with a Zeiss Axiocam. Fluorescent and DIC images from sectioned tissue were obtained using a Zeiss LSM5 Confocal microscope. Single plane or compressed z-stacks were analyzed for quantitative data on cilia and cell morphology. 8-10 eyes were analyzed for each category and statistical significance was calculated using an unpaired t-test.
Renal histology
Kidney tissue was available from right sided nephrectomy at the time of living related kidney transplantation. Kidney tissue blocks were fixed in formaldehyde, dehydrated, embedded in paraffin, sectioned at 1-2 µm and assessed by routine staining (Hematoxylineosin (H&E), Periodic acid-Schiff (PAS)).
RESULTS
Patient phenotypes
The index patient (V:12), is a 9½-year-old boy, the second child of consanguineous Iraqi parents (Fig. 1A, Fig. 2A ). Oligohydramnios and enlarged kidneys were noted at gestational week 22. Patient V:12 was born at 35 weeks by Caesarean section with massively enlarged polycystic kidneys ( Fig. 1C -G) , birth weight of 2610 g (P50), length of 44 cm (P3) and head circumference of 34.5 cm (P50). There was no gross facial dysmorphism, polydactyly or heterotaxia. He required intensive care and ventilation immediately after birth. Renal function was severely compromised but improved with conservative management. The patient received a preemptive living related kidney graft from his father at 4.5 years of age to avoid dialysis and associated comorbidities. Liver fibrosis, pancreatic and liver cysts, frequent symptoms of ARPKD, were excluded by tissue biopsy and repeated abdominal imaging. Lack of fixation, horizontal and vertical head nodding were evident at four months of age. Ophthalmological examination revealed no better visual function than fixation to light, slow pupil reaction to light, pendular nystagmus with jerk and rotatory components, and no response in visually evoked potentials and electroretinography, compatible with LCA. Eye movements indicated oculomotor apraxia, and a seesaw nystagmus, both typical of JBTS. Fundus examination revealed a small coloboma next to the papilla (right) and small vessel diameter (both eyes). Cranial MRI revealed an MTS (cerebellar vermis hypoplasia, thick and maloriented superior cerebellar peduncles, abnormally deep interpeduncular fossa; Fig. 1B ). The patient is mentally retarded. There were at least four additional similarly affected individuals in the family ( Fig. 2A) with massively enlarged polycystic kidneys who all died from lung hypoplasia and/or endstage renal disease (ESRD) between neonatal and early school age. Blindness, ataxia, and mental retardation were reported in two girls (IV:1, IV:6) who died at the ages of 6½ and 9 years, respectively. Two affected boys (V:1, V:2) died too early (one and two days after birth) for blindness to be recognized clinically (clinical synopsis in Supp. Table S2 ).
Genetic investigations
Next-generation sequencing (NGS) of 21 JBTS genes (except CSPP1, which has only recently been reported), 76 RP and 27 LCA genes, did not identify any point mutations or large structural rearrangements (quantitative analysis of NGS reads, ). Testing for homozygous deletion of NPHP1, a common cause of JBTS with NPHP, and direct sequencing of PKHD1, the only known ARPKD gene, revealed no mutation. Assuming a homozygous recessive mutation, we carried out genome-wide linkage analysis, based on DNA from the index patient, his brother and his parents. We identified twelve regions of homozygosity by descent (HBD) with a combined maximum parametric LOD score of 1.33 on chromosomes 2 (2×), 6, 7, 9, 10, 12, 13, 15, 17 (2×) and 19 (Fig. 2B) . Subsequent whole-exome sequencing (WES) for a sample of the index patient (mean coverage of 101-fold (30-fold for 90%, and 10-fold for 97% of target sequences, respectively)) revealed 19 homozygous candidate variants in the HBD regions (Supp. Table  S3 ). We queried the Ciliaproteome database (V3) [Gherman et al., 2006] and Pubmed for the genes with these rare variants: Only two genes, ABCB6 and POC1B (also called WDR51B and PIX1; MIM# 614784), each carrying a homozygous missense variant, had documented ciliary expression. In contrast to the POC1B variant, the ABCB6 variant p.Leu425Val (c.1273C>G) has been annotated in dbSNP (rs111852229; MAF: C=0.001/3). No MAF was available for p.Arg106Pro (c.317G>C) in POC1B (RefSeq accession number NM_172240.2). Bioinformatic programs predict pathogenicity of this variant in exon 4 of POC1B (Fig. 2C) , which affects an evolutionarily highly conserved position (Fig. 2D , Supp. Table S2 ). While ABCB6 mutations cause the recessive Lan(−) blood group phenotype [Helias et al., 2012] or dominant ocular coloboma , mutations in a protein closely related to POC1B, POC1A (MIM# 614783), underlie two similar recessive ciliopathies (with a truncation causing primordial dwarfism [Shaheen et al., 2012] , and a missense mutation underlying short stature, onychodysplasia, facial dysmorphism and hypotrichosis (SOFT) syndrome [Sarig et al., 2012] ). We thus focused on POC1B as the likely disease gene. Segregation analysis including recently obtained samples from 10 additional healthy family members was compatible with a causative role of the POC1B mutation; all six consanguineous parents of affected individuals (IV:1, IV:6; V:1, V:2, V:12) were heterozygous carriers ( Fig. 2A,D) . The LOD score for c.317G>C in POC1B, considering the extended segregation analysis, was 2.61, compared to 1.33 for the 12 HBD regions from initial linkage analysis (Fig. 2B) . 18 genes, including five with documented or likely ciliary expression, were found to carry at least two rare variants (Supp . Table S1 ). However, none of these genes appeared to be a convincing candidate for disease in our family (mutated in unrelated diseases; pathogenicity unlikely based on bioinformatic predictions; documented MAFs in general population).
Prediction of WD40 structure in wild-type, mutant and variant POC1B protein
The p.Arg106Pro mutation affects an evolutionarily highly conserved residue of POC1B (Fig. 2E) . We predicted the structure of POC1B using the WD40 structure predictor [Wang et al., 2013] . The seven WD40 blades are well defined in the wild-type protein (Fig. 3A) , each exhibiting a β-bulge formed between the beginning of strand a and the end of strand b (WD b-a bulge) [Wu et al., 2012] . The side chains of several residues, including p.Arg106, extrude from the top face of the propeller and are putative hotspots for protein-protein interaction [Wang et al., 2013; Wu et al., 2012] . Proline is known to disrupt β-sheets and, not allowing an inter-strand hydrogen bond, is very rare in β-bulge structures. The p.Arg106Pro mutation is thus expected to perturb the structure of the top face of the protein (Fig. 3B) , to destabilize the protein and to compromise protein-protein interactions [Wu et al., 2012] . In contrast, the known p.Arg106Gln variant (SNP rs76216585) has only a minor effect on structure because the side chains of Arg and Gln are both extended (Fig. 3C) . Furthermore, the assumed salt bridge between p.Arg106 and p.Glu122 in the wild-type protein would likely be replaced by a hydrogen bond between p.Gln106 and p.Glu122 in the variant protein. In the p.Arg106Pro mutant, such an electrostatic stabilization is predicted to be absent, supporting the interpretation that a proline residue (but not glutamine) at position 106 of the POC1B protein is disease-causing.
Endogenous expression and centrosomal localization of mutant POC1B in transfected HEK293T cells correspond to wild-type protein
As determined by Western blot, POC1B expression in lymphoblastoid cell lines from patient V:12 appeared normal compared to wild-type cells (data not shown). In HEK293T cells transfected with a plasmid containing the p.Arg106Pro mutation, the protein localized normally at the centrosome (Supp. Fig. S1 ).
Localization of POC1B in the human retina
We analyzed the distribution of POC1B in the retina by labeling donor human retina from a 56-year old healthy individual and sections of BI6 mouse retina with POC1B antibodies. In both, POC1B was detected predominantly in the ciliary region of photoreceptor cells and synapses of the outer plexiform layer ( Fig. 4A ; mouse data not shown). Indirect immunofluorescence double labeling with antibodies against POC1B and centrin-3 (a molecular marker of the connecting cilium, the basal body (mother centriole) and the daughter centriole adjacent to the cilium) and high magnification of merged images revealed POC1B localization in the periciliary region at the basal body and the adjacent centriole of the photoreceptor cilium ( Fig. 4B,C ; scheme in Fig. 4D ).
Knockdown of Poc1b in zebrafish
Using previously published morpholino oligonucleotides (both translation and splice blocking) to knock down poc1b in zebrafish larvae (Fig. 5, Supp. Fig. S2 ) confirmed the reported ciliopathy phenotype [Pearson et al., 2009] with overall reduced eye size, heart edema, curved tail, abnormal melanocyte distribution and large pronephric cysts (Fig. 5B ) which were also detectable in histological sections (Fig. 5D ). Most animals did not survive past 5 days post fertilization (dpf). Sectioned retinas from 4 and 5 dpf larvae showed intact retinal structure with distinct cell and plexiform layers (Fig. 5 E-J) , but increased cell death throughout the retina (Fig. 5 F) . The outer nuclear layer thickness of 4 dpf poc1b morphants was not significantly different from that of controls (10.31±0.122 µm and 10.39±0.134 µm, respectively; p=0.69). However, both the number and length of connecting cilia in the region of the central retina immediately dorsal to the optic nerve were reduced in morphants (Fig. 5  I) . poc1b retinas had an average of 50 ± 2.02 connecting cilia in this region compared to 74 ± 3.96 in controls (p<0.0001), and an average cilia length of 1.29 ± 0.08 µm compared to 1.98 ± 0.06 µm in controls (p<0.0001). We also examined morphology of the red-green double cones (Fig. 5 J) . Measuring from the pedicle to the apical inner segment (the limits of the antibody localization), we noted a significant reduction in the apicobasal length of these cells in poc1b morphants compared to controls (12.2 ± 1.15 µm and 16.16 ± 1.07 µm, respectively; p<0.0001).
Mutation screening of POC1B in a cohort of JBTS patients
We analyzed WES datasets from 19 JBTS patients without mutations in known JBTS genes, and we sequenced the 12 coding exons of POC1B in four patients with the cerebello-oculorenal form of JBTS, but no mutations were identified in this cohort.
DISCUSSION
Humans have two related POC1 (proteome of centriole 1) proteins, POC1A and POC1B, that are required for centriole integrity, basal body stability and ciliogenesis [Pearson et al., 2009] . Their depletion leads to loss of centrioles (barrel-shaped structures of nine triplets of highly stabilized microtubules) and aberrant cell division [Venoux et al., 2013] . In the early stage of the cell division cycle, cells have two centrioles that together with surrounding pericentriolar material constitute a centrosome, the site from which most cytoplasmic microtubules are nucleated. As cells progress into S-phase before cell division, the centrioles duplicate to generate two centrosomes (each with two centrioles) that form the poles of the mitotic spindle. If cells exit the cell cycle into a post-mitotic quiescent or differentiated state, the two centrioles migrate to the cell surface where the mother centriole differentiates to the basal body, which contributes to formation of the primary cilium.
POC1 proteins have a conserved structure with an N-terminal WD40 repeat domain, highly conserved 40 -60 amino acid motifs preferentially ending with a tryptophan (W) and an aspartic acid (D), that are separated by a spacer sequence from the C-terminal coiled coil domain. WD40 repeats are among the most abundant and highly conserved protein domains from bacteria to mammals. They form β-propeller structures, a platform for binding other proteins and maintaining the integrity of the respective protein complex [Migliori et al., 2012] . Through key protein-protein interactions via the WD40 domain, POC1 proteins contribute to formation and maintenance of the basal body and, potentially, the transition zone that assembles between the distal end of the basal body and the axonemal microtubules of the cilium. These are the sites where LCA, NPHP and JBTS proteins are typically located and interact to assemble functional complexes [Sang et al., 2011] . Mutations disrupting WD40 structure in AHI1 and WDR34 cause JBTS [Ferland et al., 2004] and Jeune syndrome [Huber et al., 2013; Schmidts et al., 2013] , respectively, indicating the importance of WD40 proteins for ciliary integrity.
POC1B localizes in the periciliary compartment at the basal body and the adjacent centriole of primary cilia of photoreceptors ( Fig. 4B,C ; scheme in Fig. 4D ). This subciliary compartment is characterized by modules that regulate the delivery of ciliary components into the cilium, namely the BBSome [Nachury et al., 2010] . As in other primary cilia, the molecular components of the intraflagellar transport (IFT) machinery are assembled in this periciliary region of the photoreceptor cilium [Sedmak and Wolfrum, 2010] . This strategic site is a localization hotspot of proteins involved in isolated (e.g. TOPORS, RAB28, RP2, LCA5, FAM161A) and syndromic retinal degeneration (including JBTS with retinal degeneration, e.g. caused by NPHP1, RPGRIP1L and OFD1 mutations) [Wheway et al., 2013] , and diverse mutations in lebercilin (LCA5) disrupt its interactions with the IFT machinery [Boldt et al., 2011] . In RP28 mice, retinal pathology apparently arises from inability of truncated Fam161a to bind lebercilin and cep290. The shorter connecting cilia in RP28 mice [Karlstetter et al., 2014] resemble the defects in poc1B-deficient zebrafish, and the pathomechanisms of POC1B-and FAM161A-associated LCA may hence be similar. The p.Arg106Pro mutation does apparently not interfere with endogenous POC1B expression or its centrosomal localization (Supp. Fig. S1 ). Together with our in silico prediction suggesting a perturbation of WD40 structure by p.Arg106Pro (Fig. 3) , we speculate that rather than being mislocalized itself, POC1B p.Arg106Pro has lost its ability to bind other proteins required for normal retinal, renal and cerebellar development. Identification of the proteins interacting with POC1B will undoubtedly reveal known ciliopathy proteins and novel candidates for disease, and help understanding the pathomechanisms of POC1B deficiency.
Mutations in particular JBTS genes predispose to additional cystic kidney disease (RPGRIP1L, NPHP1, CEP290, CC2D2A, TMEM67, TMEM216, TMEM237, ZNF423), retinal degeneration (AHI1, CEP290, CC2D2A, INPP5E, OFD1) or both (CEP290, NPHP1, AHI1, TMEM231) [Romani et al., 2013] . Cystic kidney disease in JBTS typically manifests as NPHP, with small to normal-sized kidneys and cysts at the corticomedullary junction, tubular atrophy, interstitial fibrosis and tubular basement membrane changes. ESRD in NPHP occurs variably from infancy to the third decade of life. In the index patient's family, the renal disease is distinctly different from typical NPHP and is instead more reminiscent of ARPKD, based on the clinical course (prenatal onset, renal oligohydramnion, rapid progression to ESRD, lung hypoplasia) as well as macroscopic and imaging observations (massively enlarged polycystic kidneys, lung hypoplasia; Fig. 1C ). Only three JBTS children, all carrying TMEM67 mutations, have been reported with features of both ARPKD and NPHP. In contrast to patient V:12 and his family, they presented with congenital hepatic fibrosis, a symptom frequently found in ARPKD and a subset of NPHP patients, and there were no signs of retinal degeneration [Gunay-Aygun et al., 2009] . Histologically, cysts in patient V:12 appear rounded as in autosomal dominant PKD (ADPKD), but in contrast to ADPKD, cysts are mainly located in cortical and subcortical regions (Fig. 1D) . Moreover, patient V:12 has larger kidneys with more and larger cysts than typically found in ADPKD, and the degenerative histological changes (collecting ducts and most parts of the loop of Henle are absent from the medullary region; Fig. 1E ) overlap only partially with NPHP and PKD features. Congenital hepatic fibrosis was not present in the family described here. In summary, the index patient's family displays an unusual type of PKD that overlaps with (but clearly differs from) NPHP, ARPKD and ADPKD, and elucidation of the pathomechanism in the family described herein may therefore reveal common pathways for these renal diseases: POC1B malfunction could induce degeneration of medullary tubular structures with secondary cystic hypertrophy resulting in rounded cysts. Alternatively, primary ciliary dysfunction could, as in ADPKD, induce proliferation defects with subsequent cyst formation [Harris and Torres, 2009 ].
Analysis of WES datasets from 23 unrelated JBTS patients without mutations in known JBTS genes and sequencing of POC1B in four patients with cystic kidney disease and retinal degeneration failed to identify additional mutations. None of the screened patients had a PKD phenotype comparable to our family; if the rare combination of atypical PKD with LCA was obligatory for POC1B-associated JBTS, this would explain the outcome of mutation screening.
Recently, an independent study reported homozygosity for the same POC1B mutation as described in our study, p.Arg106Pro, that caused autosomal recessive non-syndromic CORD in four members of a consanguineous Turkish family [Durlu et al., 2014] . In contrast to our family, none of the patients were blind at birth, and their phenotype (decreased visual acuity, severe photophobia and impaired color vision) was categorized as severe and slowly progressive CORD. The difference in disease severity is not surprising because CORD exhibits wide clinical variability, and early-onset severe CORD may be clinically indistinguishable from LCA. Furthermore, mutations in several genes, e.g. RPGRIP1, may cause either LCA or CORD [Hamel, 2007; Khan et al., 2013] . The study by Durlu et al. supports our findings that indicate a crucial role of POC1B for retinal function and integrity.
In addition, we propose POC1B as a candidate for syndromic retinal dystrophy, JBTS with LCA and PKD. Our findings resemble a similar phenomenon for mutations in another ciliary WD40 protein, WDR19, where homozygosity for the missense mutation p.Leu710Ser has been shown to cause either non-syndromic autosomal recessive RP [Coussa et al., 2013] or a potentially lethal syndromic ciliopathy, Jeune syndrome [Bredrup et al., 2011] . Similarly, compound-heterozygosity for the same truncating mutations in ciliary IQCB1, may cause LCA either in isolation [Estrada-Cuzcano et al., 2011] or in conjunction with early renal failure due to nephronophthisis (Senior Loken syndrome) [Otto et al., 2005] . A possible explanation is the effect of modifier alleles in additional ciliary genes. For example, specific alleles of RPGRIP1L and AHI1 have been shown to influence the penetrance of retinal degeneration in ciliopathies [Khanna et al., 2009; Louie et al., 2010] . The POC1B mutation p.Arg106Pro may represent a founder allele, and the CORD family [Durlu et al., 2014] and the family with a syndromic retinal ciliopathy reported in our study may be distantly related. Differences in genetic background (due to distinct geographical origins, Turkey and Iraq) could account for disease expression of p.Arg106Pro as CORD in one family and as severe syndromic ciliopathy (JBTS) in the other.
Finally, we cannot exclude the possibility that disease in patients of the Iraqi family described herein results from homozygosity for mutations in at least two genes, with the POC1B mutation accounting for non-syndromic retinal dystrophy and a yet unknown mutation for the extraocular symptoms (JBTS, PKD). Because every individual can be expected to carry heterozygous mutations for several recessive conditions, offspring of consanguineous parents may become homozygous for more than one mutation in unlinked genes, and co-occurence of two recessive conditions may mimick a single, syndromic disorder. We have previously described this in families with suspected Navajo neurohepatopathy and Usher syndrome [Ebermann et al., 2008; Ebermann et al., 2007] . In the WES data of the index patient, there was no indication for such a scenario.
The segregation pattern of the p.Arg106Pro mutation in a large consanguineous family, the consistent phenotype of affected family members, retinal localization of POC1B at sites typical of JBTS/LCA/NPHP proteins and the early lethal renal-retinal ciliopathy phenotype in poc1b-deficient zebrafish support the hypothesis that POC1B not only causes the retinal degeneration in the family reported here, but also JBTS with PKD. However, further unrelated cases are needed to provide definitive proof for this interpretation.
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FIGURE 4. Localization of POC1B in the human retina
A Longitudinal cryosections through a human retina stained for POC1B (green) and counterstained for the ciliary marker centrin-3 (Cen3, red) reveals POC1B localization in the ciliary region (CR) of the photoreceptor layer and the synapses of the outer plexiform layer (OPL) (arrow). Overlay of DIC (differential interference contrast) image with DAPI (blue) nuclear stain in the outer (ONL) and inner nuclear layer (INL) shows retina layers. OS, outer segment; IS, inner segment. B Increased magnification of the photoreceptor cells demonstrates co-localization of POC1B and Cen3 in the photoreceptor ciliary region (CR).
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C High magnification of the photoreceptor cilium reveals substantial localization of POC1B at the centriole (Ce) and the basal body (BB) of the connecting cilium (CC), but not in the CC itself, as schematically demonstrated in D. Scale bars: A, 10 µm; B, 5 µm; C, 0.5 µm. animal. E -F Retinal cell death in poc1bMO larvae. Sectioned retinal tissue from 5dpf control animals (E) labeled with Caspase-3 (red) are negative for retinal cell death at this stage. Some autofluorescence is present in the photoreceptor outer segments. poc1bMO retinal sections (F) show normal retinal cell layers but smaller eye size relative to controls and an increase in retinal cell death, primarily in the inner nuclear layer. G -J Photoreceptor connecting cilia and outer segments are abnormal in poc1b morphants.
Compressed 10µm z-stack of retinas stained with acetylated tubulin (G, I) show the tiered arrangement and length of connecting cilia in control retinas (G). Cilia are reduced in length
